Andrew Stuart is the Bren Professor of Computing and Mathematical Sciences at the California Institute of Technology (Caltech), joining in 2016. He previously held faculty positions at the University of Warwick (1999–2016), Stanford University (1992–1999), and Bath University (1989–1992). He earned his PhD from the University of Oxford's Computing Laboratory in 1986. Professor Stuart's research focuses on applied and computational mathematics , particularly Bayesian inverse problems , data assimilation for dynamical systems , and stochastic modeling . His work bridges mathematical theory, algorithm development, and applications in geophysics, materials science, and biological systems. His recent publications emphasize operator learning , machine learning for PDEs , and uncertainty quantification . Key areas include ensemble Kalman methods , Gaussian processes , and neural operators for solving and learning from complex systems. Scientific awards include the Vannevar Bush Faculty Fellowship and election to the Royal Society of Great Britain . He advises graduate students in applied mathematics, computational science, and geophysics, including Edoardo Calvello , Hojjat Kaveh , and Florian Wolf .
Richard M. Murray is the Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and Bioengineering at the California Institute of Technology (Caltech). He holds a B.S. from Caltech (1985), M.S. from UC Berkeley (1988), and Ph.D. from UC Berkeley (1990). He has served in academic roles from Assistant Professor (1991–1997) to his current endowed professorship. He chaired the Engineering and Applied Science division (2000–2005) and Biology and Biological Engineering (2020–2024). His research focuses on feedback control in biological and autonomous systems, synthetic cells, and networked control systems. Collaborators include experts in robotics, synthetic biology, and systems biology. Key awards include the IEEE Control Systems Award and election to the National Academy of Engineering. His educational contributions span courses on control systems, robotics, and bioengineering. Current research projects include the Developer Cell initiative (Sloan Foundation), layered testing for autonomous systems (AFOSR), and microbiome-based environmental solutions (CHARMME, ARO). He advises numerous graduate students and postdocs, with notable alumni in academia and industry. Labs include facilities in Keck and Steele laboratories at Caltech. His work bridges control theory, synthetic biology, and autonomous systems to address societal challenges like environmental monitoring and safe autonomy.
Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.
Anders Damgaard is an Associate Professor and Head of BSc studies at the Department of Environmental and Resource Engineering (DTU Sustain), Technical University of Denmark. His research focuses on environmental assessment methodologies, particularly Life Cycle Assessment (LCA), and their application to waste management systems, resource recovery, and policy development. He leads the development of LCA models like EASEWASTE/EASETECH and collaborates with institutions such as the Danish EPA and Nordic Council of Ministers. Key research areas include carbon footprints of waste treatment, textile waste composition, and additive impacts in plastics recycling. Education: Not explicitly stated in provided texts. Research Interests: Waste management optimization, circular economy frameworks, sustainable technologies, and policy-driven environmental assessments. His recent publications address topics such as carbon footprints of sewage sludge treatments, Nordic textile waste composition, and challenges in plastic additive inclusion in LCA studies. He supervises PhD students in projects involving lifecycle modeling, construction waste recycling, and consumer practices in circular economies. As part of DTU Sustain, he contributes to interdisciplinary teams advancing sustainable resource management and policy solutions.
Hugo de Lasa is a Full Professor at the Department of Chemical and Biochemical Engineering, Faculty of Engineering, University of Western Ontario. He holds a Bachelor in Chemical Engineering (1968) from Universidad Nacional del Sur, Argentina, and a Doctoral degree (1971) from Université de Nancy, France. Research Focus: Catalysis, Photocatalysis, Chemical Reactor Engineering, Fluidization, Biomass Gasification Awards: Research Excellence Prize (1998), Fellow of the Chemical Institute of Canada (2000), Medal of Research and Development (2000), Doctor Honoris Causa (2004, 2018) His work spans chemical reactor design , photocatalytic hydrogen production , and fluidized bed technologies . Recent publications highlight machine learning applications in chemical equilibrium modeling and CO2 capture using microalgae. He founded the Chemical Reactor Engineering Centre (CREC) and Recat Technologies Inc. , a university spin-off commercializing reactor innovations. Awards include the Vanguard Award (2019) and Commemorative Issue in Catalysts Journal (2020). His research has generated 389 peer-reviewed publications , 14 patents , and over 10,000 citations .
Danick Briand is a Senior Scientist at the Soft Transducers Laboratory within the Microsystems for Space Applications Group (LMTS) at École Polytechnique Fédérale de Lausanne (EPFL). His work focuses on MEMS and Microsystems for environmentally friendly technology , integrating flexible and printed electronics with applications in energy harvesting , smart sensing systems , and advanced gas sensing . Research Themes : Environmental sensors using microsystem technology Green microtechnologies and micromanufacturing Ultra-low energy MEMS Energy-saving and harvesting systems Recent Publications : Developed transient biodegradable sensors and microwave sensing technologies using printed and degradable materials Explored flexible piezoelectric systems and wearable sweat analyzers for biomedical applications Advanced inkjet-printed biosensors and eco-friendly fabrication methods Labs & Collaborations : Soft Transducers Laboratory (EPFL) Laboratory for Microsystems (LMTS)
Robert J. Hamers is a Professor of Chemistry and the Steenbock Professor of Physical Science at the University of Wisconsin-Madison . He serves as the Director of the Center for Sustainable Nanotechnology , a multi-institutional collaboration, and is a Senior Editor for Accounts of Chemical Research . Additionally, he co-founded the startup Silatronix, Inc. and leads the ACS/UW-Madison Bridge to the Chemistry Doctorate Program . B.S. in Chemistry, University of Wisconsin-Madison (1980) Ph.D. in Chemistry, Cornell University (1986) Hamers' research focuses on surface chemistry, nanotechnology, and renewable energy , with specific interests in electrochemical energy storage, photoelectron emission mechanisms, and environmental impacts of nanomaterials . His group develops ultra-stable surface chemistries for energy devices and investigates charge-transfer processes at material interfaces . Recent publications highlight advances in diamond-based materials , organosilicon electrolyte additives , and environmental fate of nanomaterials . Scientific recognitions include the Wisconsin Distinguished Professor title. His work bridges fundamental surface science with applied technologies through collaborations with academic institutions, national laboratories, and industry partners like Dow Chemical . The Hamers Group actively trains graduate students and postdoctoral researchers in multidisciplinary approaches.
Professor Daniel Segrè is a faculty member at Boston University, holding the title of Professor of Biology, Bioinformatics, and Biomedical Engineering. His research focuses on systems biology, microbial ecology, and metabolic engineering, with an emphasis on understanding complex biological networks and their applications in bioenergy and biomedicine. Segrè leads the Segre Lab ( segrelab.bu.edu ), where theoretical and computational approaches are applied to study metabolism, microbial interactions, and synthetic biology. Segrè earned his PhD from the Weizmann Institute of Science, Israel. His work bridges fundamental science and applied engineering, addressing topics such as microbial community dynamics, metabolic pathway design, and environmental microbiome applications. Research Interests: Systems biology of metabolism, evolution of biochemical networks, microbial interactions, bioinformatics, and environmental microbiome engineering. His lab develops computational models (e.g., COMETS) to simulate microbial ecosystems and design synthetic microbial communities for climate change mitigation and bioenergy production. Teaching: Courses include BE 777 (Computational Genomics), BF 821 (Bioinformatics Seminar), and BF 571 (Dynamics and Evolution of Biological Networks). These courses reflect his expertise in integrating computational methods with biological systems analysis.
John M. Woodley is a distinguished Professor in the Department of Chemical and Biochemical Engineering at the Technical University of Denmark (DTU), where he leads research at the PROSYS - Process and Systems Engineering Centre and contributes to the DTU Microbes Initiative. With over 30 years of experience, he has established himself as a leading expert in biocatalysis and bioprocess engineering, with research spanning both theoretical and experimental work across multiple scales. His primary research interests focus on the interface of bioprocess engineering, process chemistry, and reaction engineering. Dr. Woodley's work encompasses multi-step biocatalysis (including systems biocatalysis and flow chemistry), downstream processing from biocatalytic reactors and fermentations (including ISPR), modeling tools for bioprocess assessment (thermodynamics, kinetics, process simulation, economic evaluation), and bio-oxidations (including oxygen supply methods). His enzymatic investigations particularly target alcohol oxidases, carbohydrate oxidases, cytochrome P450s, Baeyer-Villiger monooxygenases, and transaminases. His research portfolio demonstrates consistent innovation in sustainable chemical production, with particular emphasis on enzymatic synthesis of pharmaceuticals and chemicals from renewable resources. Analysis of his recent publications reveals a strong focus on overcoming industrial implementation challenges, particularly regarding enzyme stability in various reactor environments, optimization of multi-enzyme systems, and scale-up methodologies for biocatalytic processes. Dr. Woodley actively supervises multiple PhD students and leads several significant research projects, including 'P450-based biocatalytic processes for the pharmaceutical industry' (2025-2028), 'Integrated model for up- and downstream bioprocess intensification' (2024-2027), and 'ENFACE: A tool for prediction of enzyme stability at gas-liquid interfaces' (2024-2027). His work has resulted in an impressive publication record of 781 research outputs across various formats, including journal articles, book chapters, and conference proceedings. His research group operates within the Department of Chemical and Biochemical Engineering at DTU, utilizing advanced facilities for biocatalysis research, including specialized reactor systems for studying gas-liquid interfaces, computational modeling resources, and laboratories for enzyme characterization and bioprocess development. Through his leadership in the PROSYS center, he contributes to DTU's strategic focus on sustainable process technologies and systems engineering.
Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.
Dr. Monica E. McCallum is an Assistant Professor of Chemistry in the Department of Chemistry at the University of Pennsylvania’s School of Arts & Sciences. Her research focuses on understanding the biochemical origins of natural products and their roles in microbial communication. She leads the McCallum Lab, which employs interdisciplinary approaches combining organic synthesis, biochemistry, microbiology, and microscopy to study microbial natural products in their native contexts. Education: 2016 – Postdoctoral Fellow at Harvard University under Prof. Emily P. Balskus 2016 – PhD in Organic Chemistry from Baylor University 2013 – PhD Candidate at Colorado State University 2011 – B.S. in Chemistry from University of California, Irvine Research Interests: Dr. McCallum’s work bridges organic synthesis and microbiology to decode microbial metabolite functions. Key themes include: Synthesizing complex natural products and their biosynthetic precursors Discovering novel enzyme-catalyzed reactions Unraveling microbial communication mechanisms via natural products Investigating environmental microbial community dynamics Lab & Collaborations: The McCallum Lab emphasizes interdisciplinary collaboration, integrating techniques from organic chemistry, molecular biology, and microscopy to study natural products in situ. Current projects focus on diazeniumdiolate biosynthesis pathways and enzymatic detoxification of marine toxins.
Dr. Muhammad Abdul-Mageed is an Associate Professor in the School of Information at The University of British Columbia, with joint appointments in Linguistics and an associate membership in Computer Science. He holds the Canada Research Chair in Natural Language Processing and Machine Learning. His research focuses on deep learning, socio-pragmatics, and speech/language technologies, particularly for Arabic and African languages. He leads the UBC Deep Learning & NLP Group and co-directs SSHRC-funded grants like I Trust AI and Ensuring Full Literacy. He is a founding member of the Center for Artificial Intelligence Decision making and Action and a member of the Institute for Computing, Information, and Cognitive Systems. His work spans automatic speech recognition, machine translation, computational socio-pragmatics, and low-resource language technologies. Notable projects include developing Arabic speech recognition systems, multidialectal Arabic benchmarks, and tools for African language processing. He has authored over 100 peer-reviewed papers and leads initiatives like the NADI Arabic Dialect Identification shared task and the NileChat project for culturally-aware LLMs. His research aims to create equitable, socially-aware AI systems for health, social media, and information management.
Peter K. Kitanidis is a Professor in the Department of Civil and Environmental Engineering and the Institute for Computational and Mathematical Engineering at Stanford University . His research focuses on groundwater flow , hydrologic forecasting , and stochastic inverse modeling , with applications to pollutant remediation and CO₂ storage monitoring . Education : Diploma, National Technical University of Athens (1974) M.S., MIT (1976) Ph.D., MIT (1978) Research Interests : Groundwater modeling and contaminant transport Hydraulic tomography and aquifer characterization Stochastic methods for uncertainty quantification Bioremediation and enhanced in-situ pollutant decay Dilution and mixing processes in heterogeneous media Real-time river flow forecasting Scientific Awards : L.G. Straub Award (1979) W.L. Huber Research Prize (1994) ISI Highly Cited Researcher (2001) AGU Hydrologic Sciences Award (2011) ASCE Pioneers in Groundwater Lecturer (2011) Advising and Grants : Advised 20+ PhD and MS students (1978–2018) Principal investigator on NSF, EPA, and DOE-funded projects Developed software for groundwater data analysis and CO₂ monitoring Contributed to bioremediation protocols and hydraulic tomography algorithms Labs and Teams : Kitanidis Laboratory for groundwater crisis solutions Collaborated with Oak Ridge National Laboratory and Stanford Hydrogeology Group Mentored postdocs (2000–2017) in reactive transport and inverse modeling
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Dewey G. McCafferty is Professor of Chemistry at Duke University with appointments in Biochemistry and the Duke Cancer Institute. His research focuses on chemical biology of chromatin-modifying enzymes and ubiquitin signaling pathways relevant to neurodegeneration and infection. Notable work includes discovering the lasso peptide antibiotic Arcumycin, characterizing the Nedd4 ubiquitin ligase in Parkinson's disease models, and developing chemoproteomic approaches for target identification. Key contributions include elucidation of the futalosine pathway in Chlamydia infections, mechanisms of CPAF protease in bacterial pathogenesis, and engineering of histone demethylase enzymes. McCafferty received the Eli Lilly Award in Biological Chemistry (2005) and directs NIH-funded projects on ubiquitin ligases in neurodegeneration.
